MANUELA CONDE: Open Payments
NPI 1538823075 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 104 payments from 20 companies in 2025. Trend: 2023 $912 · 2024 $2,090 · 2025 $2,410
Food & beverage: $2,311Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $361 |
| Arcutis Biotherapeutics, Inc. | 13 | $267 |
| E.R. Squibb & Sons, L.L.C. | 6 | $202 |
| Novartis Pharmaceuticals Corporation | 7 | $191 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $171 |
| Lilly USA, LLC | 7 | $158 |
| REVANCE THERAPEUTICS, INC. | 2 | $157 |
| GENZYME CORPORATION | 6 | $157 |
| Galderma Laboratories, L.P. | 13 | $139 |
| Incyte Corporation | 5 | $118 |
Products named: Zoryve, DUPIXENT, Sotyktu, Winlevi, DAXXIFY, BOTOX, RINVOQ, OPZELURA.
Industry payments across FL — which companies pay providers there.
